ncRNA name
hsa-miR-206
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
MAPK2 signaling pathway
Cancer name
Gastric Cancer
Cancer site
Stomach
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Down
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
The down-regulation of miR-206 is associated with DDP resistance of gastric cancer cells. Up-regulating miR-2016 expression can weaken the proliferation of drug-resistant gastric cancer cells, facilitate cell apoptosis and decrease DDP resistance via targeted inhibition of MAPK3 expression.
Tissue resource
human embryonic kidney cell lines HEK-293T
normal gastric mucosal epithelial cell lines RGM-1
gastric cancer cell lines BGC823
gastric cancer cell lines SGC7901
Experiment
qRT-PCR,Western blot,Dual-luciferase reporter assay
Institute
Chinese Academy of Sciences
Junrui Biotechnology
Country
China
Continent
Asia